Lei Xu - 14 Mar 2023 Form 4 Insider Report for Feutune Light Acquisition Corp (AIEV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Mar 2023, 17:11:48 UTC
Prior SEC filing
12 Jan 2023
Next SEC filing
25 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lei Xu

Key filing fact

Lei Xu filed Form 4 for Feutune Light Acquisition Corp (AIEV) on 16 Mar 2023.

Key facts

  • This page summarizes Lei Xu's Form 4 filing for Feutune Light Acquisition Corp (AIEV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Mar 2023, 17:11.

Change

  • Previous filing in this sequence was filed on 12 Jan 2023.
  • Current net transaction value: -$265.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FLFV transaction

Class B Common Stock

Sale

Transaction value
$265
Shares
-26,010
Change %
-17%
Price
$0.0102
Shares after
126,990
Date
14 Mar 2023
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Class B common stock will automatically convert into Class A common stock on one-for-one basis, subject to certain adjustments as provided in the amended and restated certificate of incorporation of Feutune Light Acquisition Corporation (the "Issuer") upon the consummation of an initial business combination

Footnote F2

Representing 26,010 shares of Class B Common Stock that Dr. Xu transferred to Feutune Light Sponsor LLC (the "Sponsor") pursuant to certain securities transfer agreement dated March 14, 2023 among Sponsor and certain initial stockholders of the Issuer

Footnote F3

Including (i) 153,000 shares if Class B Common Stock that Dr. Xu acquired from the Sponsor, pursuant to a securities transfer agreement dated June 15, 2022, among Sponsor and certain initial stockholders of the Issuer, and (ii) 23,970 shares of Class B Common Stock that Dr. Xu transferred to the Sponsor pursuant to certain securities transfer agreement dated March 14, 2023 among Sponsor and certain initial stockholders of the Issuer, as disclosed in footnote 2.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .